HanchorBio Inc. (TPE:7827)
Taiwan · Delayed Price · Currency is TWD 159.50
-2.50 (-1.54%)
At close: Aug 28, 2026
HanchorBio Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 1,758 | 1,064 | 405.5 | 341.87 | 246.09 |
Trading Asset Securities | - | - | - | 73.56 | - |
Cash & Short-Term Investments | 1,758 | 1,064 | 405.5 | 415.43 | 246.09 |
Cash Growth | 523.71% | 162.49% | -2.39% | 68.81% | - |
Other Receivables | 0.16 | 4.6 | 3.01 | 1.7 | 1.75 |
Receivables | 9.72 | 4.6 | 3.01 | 1.7 | 1.75 |
Prepaid Expenses | 37.58 | 12.46 | 10.05 | 8.73 | - |
Other Current Assets | 0.21 | 0.2 | 14.63 | 13.93 | 3.11 |
Total Current Assets | 1,823 | 1,082 | 433.18 | 439.79 | 250.95 |
Property, Plant & Equipment | 115.21 | 81.64 | 100.97 | 118.49 | 133.39 |
Other Intangible Assets | 2.39 | 3.16 | 2.86 | 3.9 | 3.47 |
Other Long-Term Assets | 9.31 | 5.14 | 4.78 | 5.48 | 5.5 |
Total Assets | 1,949 | 1,172 | 541.79 | 567.66 | 393.31 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accrued Expenses | - | 199.26 | 173.18 | 171.47 | 156.95 |
Short-Term Debt | 95.76 | 93.82 | 26.38 | 29.6 | - |
Current Portion of Long-Term Debt | - | - | - | 8.53 | 9.87 |
Current Portion of Leases | 9.25 | 7.56 | 12.32 | 11.57 | 9.76 |
Other Current Liabilities | 314.48 | 1.72 | 91.23 | 1.34 | 13.59 |
Total Current Liabilities | 445.24 | 302.36 | 303.11 | 222.51 | 190.17 |
Long-Term Debt | - | - | - | 1,277 | 8.53 |
Long-Term Leases | 35.1 | - | 7.56 | 19.88 | 26.89 |
Other Long-Term Liabilities | - | - | - | 418.91 | 1,002 |
Total Liabilities | 480.35 | 302.36 | 310.67 | 1,938 | 1,228 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 1,400 | 1,302 | 1,200 | 22.78 | 22.78 |
Additional Paid-In Capital | 3,657 | 2,584 | 1,989 | 128.54 | 75.67 |
Retained Earnings | -3,630 | -3,105 | -2,828 | -1,474 | -882.95 |
Treasury Stock | - | -0.07 | - | - | - |
Comprehensive Income & Other | -101.98 | -115.52 | -129.89 | -47.72 | -50.07 |
Total Common Equity | 1,325 | 665.74 | 231.12 | -1,371 | -834.56 |
Minority Interest | 143.94 | 203.5 | - | - | 0.04 |
Shareholders' Equity | 1,469 | 869.24 | 231.12 | -1,371 | -834.52 |
Total Liabilities & Equity | 1,949 | 1,172 | 541.79 | 567.66 | 393.31 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 140.12 | 101.38 | 46.26 | 1,347 | 55.05 |
Net Cash (Debt) | 1,618 | 963.02 | 359.24 | -931.28 | 191.04 |
Net Cash Growth | 859.97% | 168.07% | - | - | - |
Net Cash Per Share | 12.58 | 7.85 | 5.40 | -17.88 | 4.32 |
Filing Date Shares Outstanding | 133.51 | 130.01 | 120 | 65.12 | 44.25 |
Total Common Shares Outstanding | 133.51 | 130.01 | 120 | 65.12 | 44.25 |
Working Capital | 1,377 | 779.3 | 130.07 | 217.29 | 60.78 |
Book Value Per Share | 9.93 | 5.12 | 1.93 | -21.05 | -18.86 |
Tangible Book Value | 1,323 | 662.58 | 228.26 | -1,375 | -838.03 |
Tangible Book Value Per Share | 9.91 | 5.10 | 1.90 | -21.11 | -18.94 |
Machinery | - | 122.78 | 117.05 | 98.18 | 88.47 |
Construction In Progress | - | 11.57 | - | 0.42 | - |
Leasehold Improvements | - | 29.04 | 29.04 | 28.84 | 28.84 |